An Artificial Intelligence Algorithm for Early Detection of Left Ventricular Systolic Dysfunction in Patients with

Seongjin Park1, Hyo Jin Lee2, Sung-Hee Song3

  • 1Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.

PubMed

Insights

Artificial intelligence (AI) models can predict future left ventricular systolic dysfunction (LVSD) from normal electrocardiograms (ECGs) recorded years earlier. This AI-ECG approach shows promise for early detection of subclinical LVSD in asymptomatic individuals.

Area of Science:

  • Cardiology
  • Artificial Intelligence
  • Medical Imaging

Background:

  • Previous AI models for detecting left ventricular systolic dysfunction (LVSD) often used data near echocardiography or included patients with known heart disease.
  • This limitation reduced the specificity of AI for screening purposes.

Purpose of the Study:

  • To evaluate AI models' ability to predict future LVSD using electrocardiograms (ECGs) initially interpreted as normal.
  • To assess if ECGs recorded one to two years before echocardiography could predict LVSD.

Main Methods:

  • Retrospective analysis of 24,203 sinus rhythm ECGs from 11,131 patients.
  • Training and testing of two convolutional neural network models (DenseNet-121 and ResNet-101) to predict LVSD (ejection fraction ≤50%).
  • Survival analysis using Kaplan-Meier curves and log-rank tests.

Main Results:

  • Both AI models demonstrated high accuracy in predicting LVSD (AUROCs 0.930 and 0.925).
  • Patients predicted to have LVSD by AI showed a significantly higher risk of developing echocardiographic LVSD (HR 9.89).
  • Predicted LVSD was associated with significantly lower 24-month survival rates.

Conclusions:

  • AI-enabled ECG models can predict future LVSD from normal ECGs obtained up to two years prior.
  • These findings highlight the potential of AI-ECG for early detection of subclinical LVSD.
  • AI-ECG may improve risk stratification in asymptomatic individuals.